Oropouche virus ‘massively underdiagnosed’ in Latin America, new study suggests
Antibodies to the virus linked to still births and defects found at high levels in Bolivia, Colombia, Costa Rica, Ecuador, and Peru

Antibodies to the virus linked to still births and defects found at high levels in Bolivia, Colombia, Costa Rica, Ecuador, and Peru
The UK Health Security Agency has launched an investigation to determine how a person in North East England caught the virus
As a landmark WHO report warns of a lack of treatments and diagnosis, we investigate a threat that now kills twice as many people as TB
Vaccine-hesitant parents are taking treatment into their own hands after claims from the US Health Secretary, experts fear
As a landmark WHO report warns of a lack of treatments and diagnosis, we investigate a threat that now kills twice as many people as TB
The fight against antimicrobial resistance is reaching a critical moment: drug-resistant infections are outpacing our ability to treat them
Discovery in Israel raises hopes that major obstacle to developing new treatments for drug-resistant infections has been overcome
UK-funded trial conducted found levofloxacin substantially reduced the risk of children developing multi drug-resistant tuberculosis
Exclusive: Exercise Polaris, run from Geneva, tested 15 countries on their response to a deadly outbreak – with some laissez-faire results
The UK Health Security Agency has launched an investigation to determine how a person in North East England caught the virus
The threat of immigration raises concerns that cases of H5N1 are potentially being missed
The consequences of failing to strike a deal extend well beyond how the world will grapple with health emergencies
Overall new infections and deaths could match numbers last seen in the early 2000s, according to peer-reviewed study
Trump is poised to stop funding vaccines for developing countries. It’s a huge mistake for MAGA from an economic and security point of view
The ‘relatively small’ infections detected in Britain so far is the ‘tip of a potential iceberg’, UKHSA’s annual conference is told
Trial could ‘usher in a new era’ of affordable antibody therapies to protect against dangerous infectious diseases like Mers, Ebola and mpox
Thousands have been infected and two have been killed by the debilitating, mosquito-borne virus in the space of a few weeks
Pathogens like measles, whooping cough, and tuberculosis cost taxpayers £6 billion in 2024 alone
New database identifies 24 viral, bacterial and fungal diseases that leave Britain vulnerable to future outbreaks
The road to recovery has been rocky for those affected – half a decade later the effects of Sars-Cov-2 are far from over